Beacon Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$732K Sell
8,451
-220
-3% -$21.1K 0.28% 81
2025
Q4
$833K Sell
8,671
-49
-0.6% -$4.76K 0.33% 78
2025
Q3
$831K Sell
8,720
-41
-0.5% -$3.77K 0.34% 80
2025
Q2
$754K Buy
8,761
+31
+0.4% +$2.63K 0.33% 79
2025
Q1
$785K Sell
8,730
-18
-0.2% -$1.61K 0.37% 75
2024
Q4
$699K Buy
8,748
+30
+0.3% +$2.6K 0.33% 77
2024
Q3
$785K Buy
8,718
+13
+0.1% +$1.09K 0.37% 75
2024
Q2
$685K Sell
8,705
-330
-4% -$27.1K 0.35% 77
2024
Q1
$787K Buy
9,035
+80
+0.9% +$6.83K 0.45% 61
2023
Q4
$738K Buy
8,955
+37
+0.4% +$2.82K 0.47% 61
2023
Q3
$699K Buy
8,918
+33
+0.4% +$2.76K 0.49% 58
2023
Q2
$783K Sell
8,885
-273
-3% -$23.5K 0.53% 55
2023
Q1
$738K Buy
9,158
+156
+2% +$12.7K 0.54% 60
2022
Q4
$700K Buy
+9,002
New +$730K 0.58% 56

Other funds holding MDT

Beacon Investment Advisors's MDT Position: Q1 2026 in Review

Beacon Investment Advisors reduced its Medtronic (MDT) stake by 2.5% in Q1 2026, selling an estimated $21.1K and leaving 8,451 shares worth $732K. The position accounts for 0.28% of the portfolio, ranked #81.

Beacon Investment Advisors first reported a position in MDT in Q4 2022 and has held it in 14 quarters since. The position peaked at $833K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Beacon Investment Advisors held 8,451 shares of Medtronic worth $732K as of Q1 2026.
  • Beacon Investment Advisors sold 220 Medtronic shares in Q1 2026, an estimated $21.1K.
  • Medtronic made up 0.28% of Beacon Investment Advisors's portfolio in Q1 2026, its #81 holding.
  • Beacon Investment Advisors first reported a position in Medtronic in Q4 2022 and has held it in 14 quarters since.
  • Beacon Investment Advisors's Medtronic position peaked at $833K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Beacon Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.